Live feed
·
INSIDERFiling
CRISPR Therapeutics AG logo

General Counsel and Secretary Kasinger James R. converted options into 3,825 shares and sold $111,049 worth of shares (2,112 units at $52.58), increasing direct ownership by 2% to 85,115 units (SEC Form 4)